| Predicate |
Object |
| contentType |
Editorial|Research Support, Non-U.S. Gov't|Comment |
| endingPage |
145 |
| issn |
0007-1161 |
| issueIdentifier |
2 |
| pageRange |
143-145 |
| publicationName |
The British journal of ophthalmology |
| startingPage |
143 |
| bibliographicCitation |
Kaiser PK. Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand? British Journal of Ophthalmology. 2010 Feb 01;94(2):143–5. doi: 10.1136/bjo.2009.159863. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a051dd1734df96215b0b7f366bbaf4d3 |
| date |
2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1136/bjo.2009.159863
https://pubmed.ncbi.nlm.nih.gov/20139287 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1882
https://portal.issn.org/resource/ISSN/0007-1161 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand? |
| discusses |
http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0441463
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0258373
http://id.nlm.nih.gov/mesh/M0026299
http://id.nlm.nih.gov/mesh/M0017336 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011166Q000627
http://id.nlm.nih.gov/mesh/D020533Q000627
http://id.nlm.nih.gov/mesh/D020256Q000188
http://id.nlm.nih.gov/mesh/D017319Q000627
http://id.nlm.nih.gov/mesh/D008268Q000150 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077362
http://id.nlm.nih.gov/mesh/D020256Q000209
http://id.nlm.nih.gov/mesh/D010778Q000379
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D042461Q000037 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8397
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 |